Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning caused by pentazocine (disorder) |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental pentazocine poisoning |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional pentazocine poisoning (disorder) |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la pentazocine d'intention indéterminée |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine adverse reaction |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to pentazocine (finding) |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine overdose (disorder) |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental pentazocine overdose |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional pentazocine overdose |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de pentazocine d'intention indéterminée |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine 30mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine 60mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + pentazocine hydrochloride 325mg/ns tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + pentazocine hydrochloride 650mg/ns caplet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naloxone hydrochloride + pentazocine hydrochloride 0.5mg/ns tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine measurement |
Component |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen + pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental poisoning by pentazocine |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine hydrochloride |
Is a |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional pentazocine poisoning (disorder) |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine lactate |
Is a |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing pentazocine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to pentazocine (finding) |
Causative agent (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aspirin and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine lactate |
Is modification of (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine hydrochloride |
Is modification of (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing naloxone and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing naloxone and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely pentazocine (as pentazocine lactate) 30 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pentazocine (as pentazocine lactate) 60 milligram/2 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin and pentazocine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naloxone and pentazocine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Pentazocine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pentazocine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only naloxone and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to pentazocine (finding) |
Causative agent (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pentazocine (as pentazocine lactate) 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing paracetamol and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol- and pentazocine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
Has precise active ingredient |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only paracetamol and pentazocine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only paracetamol and pentazocine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pentazocine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |